US.IQV · IQVIA

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.9960143953865894,
        "turnoverUsdM": 666.84607489084,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.IQV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 200.4814,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 3
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.3,
      "stop_loss_percent": 6,
      "take_profit_price": 229.2439,
      "target_multiplier": 1.9,
      "technical_strength": 1.98,
      "take_profit_percent": 7.5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2516628777800383,
    "stopLossPercent": 5.992028790773179,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 77,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 57,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 20
  },
  "market": {
    "ma20": 205.158,
    "ma50": 188.4008,
    "close": 213.26,
    "prevClose": 208.05,
    "avgVolume20": 1290206,
    "volumeRatio": 2.42,
    "changePercent": 2.5
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 20,
    "details": {
      "ret_5d": 0.04590485757257756,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 20,
      "vcp_bonus": 0,
      "vol_ratio": 2.557563910143422,
      "ret_points": 8,
      "vol_points": 8,
      "range_ratio": 1.0703059121601355,
      "volat_points": 0,
      "day_range_pct": 0.03099503099479647,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 77,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 50,
        "contribution": 2.5
      },
      {
        "raw": 12.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 62,
        "contribution": 12.4
      },
      {
        "raw": 4.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 30.67,
        "contribution": 4.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 24.7,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 82.33,
        "contribution": 24.7
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "觀望",
    "result": 57,
    "details": [
      "基本面分析總分: 2.5/5分",
      "資金流分析總分: 12.4/20分",
      "市場環境分析總分: 4.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 24.7/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.5,
      "資金流": 12.4,
      "市場環境": 4.6,
      "情緒分析": 4,
      "技術信號": 24.7,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.3,
          "marginPoints": 0,
          "turnoverUsdM": 666.84607489084,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 2.4,
          "obvPoints": 2.4,
          "vwapPoints": 3.2,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.IQV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 710.4899991500001,
                "ma50": 717.6342017599999,
                "name": "QQQ",
                "close": 682.059998,
                "points": 0.4
              },
              "spy": {
                "ma20": 746.6545068500001,
                "ma50": 745.00220184,
                "name": "SPY",
                "close": 739.02002,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.9960143953865894,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141030716,
                "url": "https://finnhub.io/api/news?id=fe6ae75100661458ba44b3a11bdeb826743bd04387a386da065ea71a222938fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday before market hours. Here’s what you need to know.",
                "category": "company",
                "datetime": 1785125102,
                "headline": "Earnings To Watch: IQVIA (IQV) Reports Q2 Results Tomorrow"
              },
              {
                "id": 140971967,
                "url": "https://finnhub.io/api/news?id=809cac922a425d1b82ae91df57b889a6510c30808d6c2f0cf632e616076cf561",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784642411,
                "headline": "IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 140900022,
                "url": "https://finnhub.io/api/news?id=b44833f5389aecadc9df2d742388cd3c5e6f04fbd706885c31c48b5ff180eec6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQV vs. PEN: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1784043604,
                "headline": "IQV vs. PEN: Which Stock Is the Better Value Option?"
              },
              {
                "id": 140853815,
                "url": "https://finnhub.io/api/news?id=0d4b5d1372f765dee0831db8ff41ec64da37f1e079c9b7d2f2fd6e19f6f7ef5e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Artisan Partners has initiated a new position in IQVIA Holdings (NYSE:IQV), highlighting its view on the company's resilience and AI upside. The investor has publicly argued that IQVIA's exposure to AI could support the business, even as parts of the clinical research industry face concern about disruption and demand softness. IQVIA Holdings, trading at $203.79, sits at an interesting point for investors, with the stock up 10.9% over the past 30 days and 25.8% over the past year. Longer...",
                "category": "company",
                "datetime": 1783613493,
                "headline": "IQVIA (IQV) Just Drew A New Artisan Partners Bet On AI And Resilience"
              },
              {
                "id": 140839745,
                "url": "https://finnhub.io/api/news?id=947ff7c015dd5d601528dcceb1f766e3f743ffab0cc88bacc2924303f5229d63",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Artisan Partners, an investment management firm, issued its first-quarter 2026 investor letter for the “Artisan Mid Cap Value Fund”. A copy of this letter is available for download here. In Q1 2026, the portfolio underperformed the benchmark Russell Midcap Value Index as the market favored momentum-driven stocks over quality factors. Some holdings faced company-specific setbacks and […]",
                "category": "company",
                "datetime": 1783510149,
                "headline": "Is IQVIA Holdings (IQV) Resilient to AI Concerns?"
              },
              {
                "id": 140799783,
                "url": "https://finnhub.io/api/news?id=eee64857314f39c9472db28dd09d97052f5d00be3dfa853a03103695eab988ef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA's AI tools, record R&D backlog and strong free cash flow support its outlook, but weak liquidity and no dividend remain investor concerns.",
                "category": "company",
                "datetime": 1783081860,
                "headline": "Here's Why Investors Should Hold IQV Stock in Their Portfolios Now"
              },
              {
                "id": 140791596,
                "url": "https://finnhub.io/api/news?id=c51f8424b296fcc2683578250a458faadfa2ba9b1eddc5d5330cd1930a1ecabc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Hardman Johnston Global Advisors, an investment management firm, issued its investor letter for the Hardman Johnston Large Cap Equity Strategy for the first quarter of 2026. A copy of the letter can be downloaded here. The strategy achieved a return of 0.68% (gross) and 0.57% (net) during this period, in contrast to a -4.33% return […]",
                "category": "company",
                "datetime": 1783000874,
                "headline": "Hardman Johnston Large Cap Equity Holds Firm on IQVIA Holdings (IQV). Here’s Why"
              },
              {
                "id": 140783823,
                "url": "https://finnhub.io/api/news?id=c919aa1bd37367561dba32e39e55195e7a75ae37498c952e1918b794b7e6986d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Shares of clinical research company IQVIA (NYSE: IQV) jumped 5.8% in the afternoon session after Baird raised its price target on the stock to $249 from $230 and designated it a 'bullish Fresh Pick'.",
                "category": "company",
                "datetime": 1782930780,
                "headline": "Why Is IQVIA (IQV) Stock Soaring Today"
              }
            ],
            "raw_source": [
              {
                "id": 141030716,
                "url": "https://finnhub.io/api/news?id=fe6ae75100661458ba44b3a11bdeb826743bd04387a386da065ea71a222938fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday before market hours. Here’s what you need to know.",
                "category": "company",
                "datetime": 1785125102,
                "headline": "Earnings To Watch: IQVIA (IQV) Reports Q2 Results Tomorrow"
              },
              {
                "id": 141009510,
                "url": "https://finnhub.io/api/news?id=0ea98b5cfec8903564b9b7fd9a9928f954f8ad2c0cb4d13fa5f4de08cd5ad128",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQV heads into its Q2'26 earnings release with y/y revenue and EPS growth expected, supported by AI adoption, drug launches and high-margin segment gains.",
                "category": "company",
                "datetime": 1784912040,
                "headline": "IQVIA Gears Up to Report Q2 Earnings: What's in the Offing?"
              },
              {
                "id": 140993990,
                "url": "https://finnhub.io/api/news?id=5206b71e1b095efb2af34273688ebb056f5dbbce6ba73d7fae75c33032ce9e3b",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "Let's have a look at the S&P500 gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1784817301,
                "headline": "Which S&P500 stocks are gapping on Thursday?"
              },
              {
                "id": 140994976,
                "url": "https://finnhub.io/api/news?id=097653050ee58c103bdd7d4f187954d4de687166f8ac36546ca10d85cf415255",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Veracyte (VCYT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784815233,
                "headline": "Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline"
              },
              {
                "id": 140983411,
                "url": "https://finnhub.io/api/news?id=20c8f45f6c754dd551cf0b30adb0791c0967233c42d9fcfbf0a589f8e2e88922",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155443326/image_155443326.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "Harris Associates’ Q1 2026 13F: portfolio fell to $75B; added CRM, ICE, KDP, ABNB, IQV; trimmed GOOGL, COP, PSX, GM. Read more macro analysis here.",
                "category": "company",
                "datetime": 1784721548,
                "headline": "Tracking William Nygren's Harris Associates Portfolio - Q1 2026 Update"
              },
              {
                "id": 140971967,
                "url": "https://finnhub.io/api/news?id=809cac922a425d1b82ae91df57b889a6510c30808d6c2f0cf632e616076cf561",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784642411,
                "headline": "IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 140944469,
                "url": "https://finnhub.io/api/news?id=b5473b5e218fa09a16b46b6e5c24f774f88167fed580755ba05200e7f3171e3c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2170932409/image_2170932409.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "Discover dividend stocks and REITs to hedge AI bubble risk, geopolitics, and inflation. Click for this survey of great income choices and my ultimate pick.",
                "category": "company",
                "datetime": 1784379799,
                "headline": "AI Bubble Risks Make Dividend Stocks Attractive Again"
              },
              {
                "id": 140922858,
                "url": "https://finnhub.io/api/news?id=35865694f3ee532a45464d1fff1bef26493abd943e7103abdac17cd37b6e2d33",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., July 16, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the U.S. House Committee on Energy and Commerce Subcommittee on Health hearing, \"Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancin",
                "category": "company",
                "datetime": 1784223540,
                "headline": "IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States"
              },
              {
                "id": 140900022,
                "url": "https://finnhub.io/api/news?id=b44833f5389aecadc9df2d742388cd3c5e6f04fbd706885c31c48b5ff180eec6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQV vs. PEN: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1784043604,
                "headline": "IQV vs. PEN: Which Stock Is the Better Value Option?"
              },
              {
                "id": 140889350,
                "url": "https://finnhub.io/api/news?id=b571faf2ef430860ea95050216e8682e00b7d3f614ec59f17ec42510fae00380",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "Mizuho  analyst Ann Hynes   maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $215 to $230.",
                "category": "company",
                "datetime": 1783925940,
                "headline": "Mizuho Maintains Outperform on IQVIA Holdings, Raises Price Target to $230"
              },
              {
                "id": 140859193,
                "url": "https://finnhub.io/api/news?id=b29f798fe32b5bc5f9ed9ec803de4657dd361a5a745dd5b08bbec1cfb437eab4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
                "category": "company",
                "datetime": 1783669396,
                "headline": "1 Cash-Producing Stock to Target This Week and 2 We Question"
              },
              {
                "id": 140853815,
                "url": "https://finnhub.io/api/news?id=0d4b5d1372f765dee0831db8ff41ec64da37f1e079c9b7d2f2fd6e19f6f7ef5e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Artisan Partners has initiated a new position in IQVIA Holdings (NYSE:IQV), highlighting its view on the company's resilience and AI upside. The investor has publicly argued that IQVIA's exposure to AI could support the business, even as parts of the clinical research industry face concern about disruption and demand softness. IQVIA Holdings, trading at $203.79, sits at an interesting point for investors, with the stock up 10.9% over the past 30 days and 25.8% over the past year. Longer...",
                "category": "company",
                "datetime": 1783613493,
                "headline": "IQVIA (IQV) Just Drew A New Artisan Partners Bet On AI And Resilience"
              },
              {
                "id": 140845613,
                "url": "https://finnhub.io/api/news?id=1b1907228305dfae0ec55bf52e972fe754e9c7afe6332a26fead6defd05394d0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., July 08, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its second-quarter 2026 financial results before the market opens on Tuesday, July 28, 2026. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time that same day. The earnings release and accompanying fin",
                "category": "company",
                "datetime": 1783541700,
                "headline": "IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026"
              },
              {
                "id": 140844609,
                "url": "https://finnhub.io/api/news?id=06debdbe96e5a3379434f0d812c343f6aedc7cf9a24b24158b5f6af43a5df122",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "ICLR is tapping CRO demand, AI workflows and wider trial access, but uneven revenue trends and margin resets keep its earnings recovery in focus.",
                "category": "company",
                "datetime": 1783534140,
                "headline": "ICON Stock and the CRO Trends Shaping Its Next Growth Phase"
              },
              {
                "id": 140839745,
                "url": "https://finnhub.io/api/news?id=947ff7c015dd5d601528dcceb1f766e3f743ffab0cc88bacc2924303f5229d63",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Artisan Partners, an investment management firm, issued its first-quarter 2026 investor letter for the “Artisan Mid Cap Value Fund”. A copy of this letter is available for download here. In Q1 2026, the portfolio underperformed the benchmark Russell Midcap Value Index as the market favored momentum-driven stocks over quality factors. Some holdings faced company-specific setbacks and […]",
                "category": "company",
                "datetime": 1783510149,
                "headline": "Is IQVIA Holdings (IQV) Resilient to AI Concerns?"
              },
              {
                "id": 140836436,
                "url": "https://finnhub.io/api/news?id=fa4e19d42e0ccc7f270ccb12c56cbb173441933db6bb9915852c17bc69c6eb29",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Amazon.com's AI push, global expansion and diversified businesses support growth, but rising AI spending, debt and competition pose challenges.",
                "category": "company",
                "datetime": 1783458900,
                "headline": "Top Analyst Reports for Amazon.com, Walmart & American Express"
              },
              {
                "id": 140833081,
                "url": "https://finnhub.io/api/news?id=b0014ec8d4702d066afdd40170bd94d682cbf383639c0f354276b70518ac12a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "ICON trades below its five-year median, but weaker 2026 guidance, control issues and leverage keep the stock in wait-and-see territory.",
                "category": "company",
                "datetime": 1783441380,
                "headline": "Is ICLR Stock a Value Trap or Turnaround After an Earnings Reset?"
              },
              {
                "id": 140831666,
                "url": "https://finnhub.io/api/news?id=b42db579b28559beb0c3dd7036e41c5bf5256c1ebd275e54eaa52f4f1cd19a5a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "MEDP's 2026 outlook highlights shifting CRO demand, longer award-to-revenue timing and steady margins, while AI investment delays near-term productivity gains.",
                "category": "company",
                "datetime": 1783432320,
                "headline": "Medpace Growth Trends Show How CRO Demand Is Shifting in 2026"
              },
              {
                "id": 140823642,
                "url": "https://finnhub.io/api/news?id=3820f8eaebd3d9d4c79c9185413716efebd2aa61d4eaf563fdc2dd499d3c1d4b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "ICON's stronger bookings and backlog hint at improving demand, but margin pressure, earnings declines and control remediation keep 2026 cautious.",
                "category": "company",
                "datetime": 1783362900,
                "headline": "ICON Stock Outlook 2026 as Margin Woes Meet a Stronger Backlog Base"
              },
              {
                "id": 140822991,
                "url": "https://finnhub.io/api/news?id=17f72a10b0544ab28833066b022947e98907839ac09695bdd7d2c169dddb3969",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1386962536/image_1386962536.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "Medpace's outlook turns cautious as bookings, backlog, and cancellations worsen vs. CRO peers. Click for more on MEDP stock.",
                "category": "company",
                "datetime": 1783348133,
                "headline": "Medpace: The Recovery Narrative Looks Premature"
              },
              {
                "id": 140821257,
                "url": "https://finnhub.io/api/news?id=965c970ee9bc1c880a7ae424ce53bb3ac5e36a3c41f0c0a4849e290c54a19678",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "MEDP's outlook hinges on whether strong backlog quality and metabolic demand can offset rising cancellations and softer proposal activity.",
                "category": "company",
                "datetime": 1783346400,
                "headline": "Medpace Stock Outlook Turns on Backlog Quality and Cancellations"
              },
              {
                "id": 140819912,
                "url": "https://finnhub.io/api/news?id=b5d2bd20e0a76d685d7676d5181354c92bbb779edc1b0cc1076343be0a7f6da6",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/628093148/image_628093148.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "Discover 5 top Big Pharma stocks amid rising cancer, type 2 diabetes and IMIDs—dividend yields, earnings beats and why they lag AI names. Click for the picks.",
                "category": "company",
                "datetime": 1783331728,
                "headline": "My Top 5 Pharma Stocks Wall Street Ignores"
              },
              {
                "id": 140799783,
                "url": "https://finnhub.io/api/news?id=eee64857314f39c9472db28dd09d97052f5d00be3dfa853a03103695eab988ef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA's AI tools, record R&D backlog and strong free cash flow support its outlook, but weak liquidity and no dividend remain investor concerns.",
                "category": "company",
                "datetime": 1783081860,
                "headline": "Here's Why Investors Should Hold IQV Stock in Their Portfolios Now"
              },
              {
                "id": 140801254,
                "url": "https://finnhub.io/api/news?id=f6ea79ac33ff949b2236e0bb99a33545c563e2e061656ba32011b0e5f0cf2f69",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings is set to announce its second-quarter earnings soon, and Wall Street expects a single-digit rise in its profits.",
                "category": "company",
                "datetime": 1783077390,
                "headline": "IQVIA Holdings' Q2 2026 Earnings: What to Expect"
              },
              {
                "id": 140791596,
                "url": "https://finnhub.io/api/news?id=c51f8424b296fcc2683578250a458faadfa2ba9b1eddc5d5330cd1930a1ecabc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Hardman Johnston Global Advisors, an investment management firm, issued its investor letter for the Hardman Johnston Large Cap Equity Strategy for the first quarter of 2026. A copy of the letter can be downloaded here. The strategy achieved a return of 0.68% (gross) and 0.57% (net) during this period, in contrast to a -4.33% return […]",
                "category": "company",
                "datetime": 1783000874,
                "headline": "Hardman Johnston Large Cap Equity Holds Firm on IQVIA Holdings (IQV). Here’s Why"
              },
              {
                "id": 140783823,
                "url": "https://finnhub.io/api/news?id=c919aa1bd37367561dba32e39e55195e7a75ae37498c952e1918b794b7e6986d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Shares of clinical research company IQVIA (NYSE: IQV) jumped 5.8% in the afternoon session after Baird raised its price target on the stock to $249 from $230 and designated it a 'bullish Fresh Pick'.",
                "category": "company",
                "datetime": 1782930780,
                "headline": "Why Is IQVIA (IQV) Stock Soaring Today"
              },
              {
                "id": 140779988,
                "url": "https://finnhub.io/api/news?id=85c4ba74d5a411c00e842f771c4320598d5ba72929a69aabb879729f4de55c1b",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/01/Palo-Alto-Networks-Inc.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, please see our analyst ratings page.",
                "category": "company",
                "datetime": 1782891968,
                "headline": "Palo Alto To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday"
              },
              {
                "id": 140780014,
                "url": "https://finnhub.io/api/news?id=6cf673d6070da12deb8d6b10da5f2cd5b5bc3a11ad0b41c6203275b644394b36",
                "image": "",
                "source": "Benzinga",
                "related": "IQV",
                "summary": "Baird  analyst Eric Coldwell   maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $230 to $249.",
                "category": "company",
                "datetime": 1782889363,
                "headline": "Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $249"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 28,
            "discarded_article_count": 20
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 24.7,
        "grade": "優秀",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 3,
          "vcpPoints": 3,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 3,
            "vcp_reason": "波幅收縮(25.7%→9.1%)；量縮(v10/v30=0.78)；跌縮量(近10日5日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 1427343.3333333333,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 1118320,
              "avg_vol_20": 1222615,
              "avg_vol_30": 1427343.3333333333,
              "range_pct_10": 0.09120319756181179,
              "range_pct_20": 0.1482697856264553,
              "range_pct_30": 0.25710403062477877,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.783497546724334,
              "dist_to_20d_high": 0.017461474073326856,
              "down_shrink_days": 5,
              "breakout_level_20d": 217.050003,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.35473266342881654
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 1.6
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.9960143953865894,
              "turnoverUsdM": 666.84607489084,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.IQV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 200.4814,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 3
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.3,
            "stop_loss_percent": 6,
            "take_profit_price": 229.2439,
            "target_multiplier": 1.9,
            "technical_strength": 1.98,
            "take_profit_percent": 7.5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2516628777800383,
          "stopLossPercent": 5.992028790773179,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.IQV",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 6.3893,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 3
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 100.53
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1516
    },
    "kdj": {
      "d": 47.53,
      "j": 69.89,
      "k": 54.99,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 57.76
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": 16100716,
      "recentSlope": 134121.6,
      "previousSlope": 192190
    },
    "rsi": 55.89,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 10,
      "trend": "上升",
      "value": 197.6,
      "position": "SAR由上轉下+趨勢強",
      "distancePct": 7.34,
      "previousTrend": "下降"
    },
    "ma50": 188.4008,
    "macd": {
      "macd": 5.799951247701927,
      "trend": "中性偏多",
      "signal": 6.380390304592017,
      "histogram": -0.5804390568900901
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 8,
      "value": 205.2412,
      "position": "連續3日>VWAP",
      "consecutiveAbove": 3
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "量價配合",
      "ratio": 2.42,
      "score": 8,
      "avgVolume": 1290206,
      "currentVolume": 3126916
    },
    "derived": {
      "ma20": 205.158,
      "ma50": 188.4008,
      "prevClose": 208.05,
      "avgVolume10": 1299962,
      "avgVolume20": 1290206,
      "changePercent": 2.5,
      "avgVolumeForScore": 1290206
    },
    "ma_cross": {
      "ma20": 205.158,
      "ma50": 188.4008,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 204.052,
      "prevMa50": 187.5832,
      "spreadPct": 8.89,
      "isVolumeBreakout": true
    },
    "bollinger": {
      "lower": 195.0902,
      "upper": 215.2258,
      "position": "上半部"
    },
    "rsi_short": 65.57,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 2.42
    }
  }
}

{
  "close": 213.26,
  "volume": 3126916,
  "changePercent": 2.5
}